Tag: FDA Advisory Committee Recommends Approval of SER120 (desmopressin nasal spray)
FDA Advisory Committee Recommends Approval of SER120 (desmopressin nasal spray)
Panel votes 14 to 4 in favor of drug in development for treatment of under-diagnosed urological disorder
DUBLIN and MILFORD, Pa., Oct. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Serenity Pharmaceuticals,...